Valuation: Zylox-Tonbridge Medical Technology Co., Ltd.

Capitalization 6.9B 7.81B 999M 841M 767M 733M 1.36B 90.44B 1.41B 8.93B 3.54B 43.67B 3.74B 3.67B 153B P/E ratio 2025 *
33.3x
P/E ratio 2026 * 23.2x
Enterprise value 6.65B 7.53B 963M 811M 740M 707M 1.31B 87.22B 1.36B 8.61B 3.42B 42.12B 3.61B 3.54B 147B EV / Sales 2025 *
6.26x
EV / Sales 2026 * 4.69x
Free-Float
33.27%
Yield 2025 *
0.52%
Yield 2026 * 0.75%
1 day-2.36%
1 week-5.16%
Current month-6.16%
1 month-9.89%
3 months-6.92%
6 months+3.49%
Current year+0.17%
1 week 22.58
Extreme 22.58
25.3
1 month 22.58
Extreme 22.58
26.84
Current year 22.32
Extreme 22.32
27.62
1 year 11.68
Extreme 11.68
28
3 years 7.2
Extreme 7.2
28
5 years 7.2
Extreme 7.2
60.8
10 years 7.2
Extreme 7.2
60.8
Manager TitleAgeSince
Chief Executive Officer 60 05/11/2012
Director of Finance/CFO 48 31/12/2020
Chief Tech/Sci/R&D Officer 60 31/12/2018
Director TitleAgeSince
Director/Board Member 63 01/03/2021
Director/Board Member 57 12/10/2020
Chairman 60 05/11/2012
Change 5d. change 1-year change 3-years change Capi.($)
-2.36%-5.16%+91.56%+44.62% 999M
+0.05%+2.17%-4.97%+38.31% 140B
+1.42%+4.58%+29.08%+15.17% 15.35B
-1.10%-3.44%-20.71%-67.62% 6.34B
+2.56%-2.71%-28.54%+116.86% 6.28B
-0.79%-4.25%+36.10%+26.73% 2.8B
+0.60%-3.51%-1.63%-23.88% 2.02B
+0.18%-9.04%-67.80%-77.88% 1.71B
-1.27%-1.05%-8.13%-33.17% 1.7B
Average -0.08%-2.62%+2.77%+4.35% 19.7B
Weighted average by Cap. +0.18%+1.60%-2.82%+32.64%

Financials

2025 *2026 *
Net sales 1.06B 1.2B 154M 130M 118M 113M 210M 13.94B 218M 1.38B 546M 6.73B 577M 565M 23.53B 1.39B 1.58B 202M 170M 155M 148M 275M 18.26B 285M 1.8B 715M 8.82B 756M 740M 30.82B
Net income 206M 233M 29.79M 25.1M 22.89M 21.85M 40.57M 2.7B 42.15M 266M 106M 1.3B 112M 109M 4.55B 293M 332M 42.45M 35.77M 32.62M 31.15M 57.82M 3.84B 60.07M 379M 151M 1.86B 159M 156M 6.49B
Net Debt -246M -278M -35.57M -29.97M -27.33M -26.1M -48.44M -3.22B -50.33M -318M -126M -1.56B -133M -131M -5.44B -360M -407M -52.09M -43.89M -40.03M -38.22M -70.94M -4.72B -73.71M -466M -185M -2.28B -195M -191M -7.96B
Logo Zylox-Tonbridge Medical Technology Co., Ltd.
Zylox-Tonbridge Medical Technology Co Ltd, formerly Zylox Medical Device Co Ltd, is a China-based company mainly engaged in the research and development of neurological and peripheral vascular interventional medical devices. The Company's main products include Thrombite Clot Retriever Device (Thrombite CRD) and Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB). The Company's products are sold to domestic and foreign markets.
Employees
875
Date Price Change Volume
13/02/26 23.14 $ -2.36% 950,801
12/02/26 23.70 $ -2.95% 563,312
11/02/26 24.42 $ -1.61% 515,826
10/02/26 24.82 $ -0.64% 730,526
09/02/26 24.98 $ +2.38% 616,953
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
20.45CNY
Average target price
26.99CNY
Spread / Average Target
+32.00%

Annual profits - Rate of surprise